Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Kaydence Pharma
Kaydence Pharma
Activities:
Ingredients
Pharmaceutical
Nutraceutical
X
LinkedIn
Trending Articles
AI in pharma: the trends and future of the tech in the industry
AI can enhance the efficiency and cost-effectiveness of a range of processes across the pharmaceutical industry, so S&P Global explores the current scope of the tech and its...
Polyplus introduces LipidBrick for LNP formulation in mRNA therapeutics
The cationic lipid broadens the scope of LNP usage in various applications from prophylactic vaccines to therapeutic and oncology applications
Strides Group launches CDMO OneSource Specialty Pharma at CPHI Milan
The newly integrated CDMO primarily specialises in the manufacture of biologics, drug-device combos and gelatin capsules
Why use corrugated tubes in heat exchangers?
There are a variety of tubular heat exchangers on the market, but for many applications corrugated tubes continue to be preferred over smooth ones. Matt Hale, International...
Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx
The acquisition strengthens Actylis’ presence in the VMS and OTC markets
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Ingredients
Vitamin K2 technology wins award for NattoPharma spin-off
Kaydence Pharma has received a start-up award at the BIO International convention
Pharmaceutical
Kaydence goes ahead with non-clinical requirements for FIH study on MQ7
The FDA has agreed on key components of the planned first-in-human study for a drug to treat arterial stiffness
Subscribe now